Encainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C22H28N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) SY3J0147NB, chemically known as benzamide, 4-methoxy-n-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)-, (+-)- but more generally known as encainide, which bears US NIH Compound Identifier 48033. European Medicines Agency schedules Encainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06519MIG. The term ENCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules encainide in its Anatomical Therapeutic Chemical (ATC) Classification. ENCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule encainide under HS 29333999 and SITC 51574. As of Q4 2014, ENCAINIDE remains US FDA's Preferred Term for this commodity. Encainide bears US NLM identifiers UMLS ID C0085251 and NCI Concept Code C65511. SMILES: O=C(NC1C(C(CN2CCCCC2)C)CCCC1)C1CCC(OC)CC1.